Adenoma immune profiles, especially CD3+ T cell density, predict future colorectal neoplasia with an odds ratio of 1.44 in a bowel screening cohort.
- Open access
Moving in Gastroenterology, Gut, The lancet. Gastroenterology & hepatology, Nature Medicine, medRxiv, mSystems, Nature Reviews Cancer and New England Journal of Medicine.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
Adenoma immune profiles, especially CD3+ T cell density, predict future colorectal neoplasia with an odds ratio of 1.44 in a bowel screening cohort.
Screening with multicancer early-detection blood tests did not significantly reduce the incidence of stage III or IV cancers after three rounds in a large randomized trial.
Gut microbiome signatures are weakly associated with colorectal neoplasia and do not serve as robust early biomarkers in a large cross-sectional study.
Persistent elevation of faecal calprotectin >70 µg/g in asymptomatic first-degree relatives predicts presymptomatic Crohn's disease with 89% sensitivity and 94% specificity.
The multi-cancer early detection (MCED) test in the PATHFINDER 2 study achieved a cancer detection rate of 0.54% among participants aged 50 or older, with a CSO prediction accuracy of 91.3%.
The multi-cancer early detection test in the NHS-Galleri trial detected primary cancers in 0.40% to 0.60% of participants across three screening rounds.
AI-assisted colonoscopy did not significantly increase adenoma detection rate in Lynch syndrome surveillance, with a difference of 2.9% (p=0.41) in a multicentre trial.
A blood-based assay detects colorectal cancer and advanced adenomas with 95% accuracy in a multicentre study, showing 91% sensitivity for colorectal cancer and 81% for advanced adenomas.
Having 5 to 10 nonadvanced adenomas is linked to a 10.1% 5-year risk of advanced colorectal neoplasm, the highest among studied groups.
Early-onset colorectal cancer (EOCRC) under age 50 is increasing globally, with lifestyle and early-life gut microbial exposures linked to its rise.
Patient navigation and mailed FIT outreach significantly increase colorectal cancer screening uptake, especially in populations with low baseline rates, with risk ratios of 1.58 and 1.36 respectively.
Journals this month
Topics moving, week to 23 Oct 2026